MultiPlan Ownership

MPLN Stock  USD 19.44  2.92  17.68%   
MultiPlan maintains a total of 16.17 Million outstanding shares. The majority of MultiPlan outstanding shares are owned by institutional investors. These third-party entities are usually referred to as non-private investors looking to shop for positions in MultiPlan to benefit from reduced commissions. Consequently, institutional holders are subject to a different set of regulations than regular investors in MultiPlan. Please pay attention to any change in the institutional holdings of MultiPlan as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in stocks such as MultiPlan in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of MultiPlan, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MultiPlan. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
To learn how to invest in MultiPlan Stock, please use our How to Invest in MultiPlan guide.

MultiPlan Stock Ownership Analysis

About 81.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.51. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. MultiPlan has Price/Earnings To Growth (PEG) ratio of 1.03. The entity recorded a loss per share of 95.28. The firm had not issued any dividends in recent years. MultiPlan had 1:40 split on the 23rd of September 2024. MultiPlan Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. MultiPlan Corporation was founded in 1980 and is headquartered in New York, New York. Multiplan Corp operates under Health Information Services classification in the United States and is traded on New York Stock Exchange. It employs 2500 people. To find out more about MultiPlan contact Mark Tabak at 212 780 2000 or learn more at https://www.multiplan.us.
Besides selling stocks to institutional investors, MultiPlan also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different MultiPlan's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align MultiPlan's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.

MultiPlan Quarterly Liabilities And Stockholders Equity

5.32 Billion

MultiPlan Insider Trades History

About 8.0% of MultiPlan are currently held by insiders. Unlike MultiPlan's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against MultiPlan's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of MultiPlan's insider trades
 
Covid

MultiPlan Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as MultiPlan is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading MultiPlan backward and forwards among themselves. MultiPlan's institutional investor refers to the entity that pools money to purchase MultiPlan's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Silver Rock Financial Lp2024-09-30
126.1 K
Charles Schwab Investment Management Inc2024-09-30
122.5 K
Millennium Management Llc2024-09-30
106.8 K
Blackrock Inc2024-09-30
106.6 K
Magnetar Financial Llc2024-09-30
99.6 K
Rbf Llc2024-09-30
90.6 K
Oak Hill Advisors Lp2024-09-30
87.5 K
Goldman Sachs Group Inc2024-09-30
58.3 K
Geode Capital Management, Llc2024-09-30
57.7 K
Atalaya Capital Management Lp2024-06-30
3.7 M
Public Investment Fund2024-09-30
1.3 M
Note, although MultiPlan's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

MultiPlan Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific MultiPlan insiders, such as employees or executives, is commonly permitted as long as it does not rely on MultiPlan's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases MultiPlan insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

MultiPlan Outstanding Bonds

MultiPlan issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. MultiPlan uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most MultiPlan bonds can be classified according to their maturity, which is the date when MultiPlan has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

MultiPlan Corporate Filings

8K
30th of January 2025
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
16th of January 2025
Other Reports
ViewVerify
3rd of January 2025
Other Reports
ViewVerify
13th of December 2024
Other Reports
ViewVerify

Pair Trading with MultiPlan

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if MultiPlan position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MultiPlan will appreciate offsetting losses from the drop in the long position's value.

Moving together with MultiPlan Stock

  0.65AHG Akso Health GroupPairCorr

Moving against MultiPlan Stock

  0.8HCAT Health CatalystPairCorr
  0.7XAIR Beyond AirPairCorr
  0.57NRC National Research CorpPairCorr
  0.5VMD Viemed HealthcarePairCorr
  0.46JYNT Joint CorpPairCorr
The ability to find closely correlated positions to MultiPlan could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace MultiPlan when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back MultiPlan - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling MultiPlan to buy it.
The correlation of MultiPlan is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as MultiPlan moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if MultiPlan moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for MultiPlan can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether MultiPlan offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of MultiPlan's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Multiplan Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Multiplan Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MultiPlan. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
To learn how to invest in MultiPlan Stock, please use our How to Invest in MultiPlan guide.
You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MultiPlan. If investors know MultiPlan will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MultiPlan listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.99)
Earnings Share
(95.28)
Revenue Per Share
58.328
Quarterly Revenue Growth
(0.05)
Return On Assets
0.0129
The market value of MultiPlan is measured differently than its book value, which is the value of MultiPlan that is recorded on the company's balance sheet. Investors also form their own opinion of MultiPlan's value that differs from its market value or its book value, called intrinsic value, which is MultiPlan's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MultiPlan's market value can be influenced by many factors that don't directly affect MultiPlan's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MultiPlan's value and its price as these two are different measures arrived at by different means. Investors typically determine if MultiPlan is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MultiPlan's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.